AREC — Arecor Therapeutics Share News
0.000.00%
- £14.35m
- £11.32m
- £5.05m
REG - Arecor Therapeutics - Result of General Meeting and Total Voting Rights
AnnouncementREG - Arecor Therapeutics - Posting of Circular and General Meeting
AnnouncementREG - Arecor Therapeutics - Result of WRAP Retail Offer
AnnouncementREG - Arecor Therapeutics - Result of Placing and Subscription
AnnouncementREG - Arecor Therapeutics - WRAP Retail Offer to raise up to £1 million
AnnouncementREG - Arecor Therapeutics - Proposed Placing and Subscription
AnnouncementREG - Arecor Therapeutics - Result of AGM
AnnouncementREG - Arecor Therapeutics - Trading and Funding Update
AnnouncementREG - Arecor Therapeutics - Posting of 2023 Annual Report and Notice of AGM
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor to host company and KOL webinar today
AnnouncementREG - Arecor Therapeutics - Positive headline results for AT278 clinical trial
AnnouncementREG - Arecor Therapeutics - Final results for 2023
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Arecor and Medtronic Diabetes collaboration
AnnouncementREG - Arecor Therapeutics - Publication of Full Year Financial Results delayed
AnnouncementREG - Arecor Therapeutics - BOARD CHANGE
AnnouncementREG - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementRCS - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
Announcement